Kc Sung

Title: Kc Sung: Innovator in Oncology

Introduction

Kc Sung is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of oncology through his innovative patents. With a total of two patents to his name, Kc Sung is recognized for his work in developing compositions and methods that enhance the efficacy of cancer treatments.

Latest Patents

Kc Sung's latest patents include "Cabozantinib compositions and methods of use" and "Kinase inhibitor salts, and compositions thereof." The first patent relates to oral compositions comprising cabozantinib salts and at least one pharmaceutically acceptable excipient. This invention aims to increase the oral bioavailability of cabozantinib while reducing the adverse events associated with its oral administration. The second patent focuses on kinase inhibitor C-Caliphatic sulfate salts, detailing compositions containing these salts and their various uses.

Career Highlights

Kc Sung is currently associated with Handa Oncology, LLC, where he continues to advance his research and development efforts in oncology. His work is pivotal in creating more effective treatment options for patients battling cancer.

Collaborations

Kc Sung collaborates with talented individuals in his field, including Fang-Yu Liu and Chin-Yao Yang. These partnerships enhance the innovative potential of his projects and contribute to the advancement of cancer treatment methodologies.

Conclusion

Kc Sung's contributions to oncology through his patents demonstrate his commitment to improving cancer therapies. His innovative work continues to pave the way for advancements in the field, ultimately benefiting patients worldwide.